Phase 2 Trial of IPI-926 In Pancreatic Cancer Treatment Initiated
Smoothened inhibition with IPI-926 represents a potentially new approach to addressing difficult-to-treat cancer.
Read MoreSearch Results for: liver disease
Testing/Diagnostics
Biochrom LtdGreiner Bio-One North AmericaViroStat IncSekisui DiagnosticsThermo Fisher Scientific IncAkonni Diagnostics
Read More
News Story #15302
Positive Early Results for Parkinson’s Treatment Michael J. Fox Harbor BioSciences, San Diego, which is investigating the use the company’s proprietary compound Triolex as a treatment for Parkinson’s disease (PD) with fund
Read MoreDaVita, Fresenius To Participate In Rockwell’s Iron-Replacement Studies
With the participation of the two largest US dialysis companies, Rockwell Medical will conduct two pivotal Phase 3 trials for Soluble Ferric Pyrophosphate as a continuous iron-replacement therapeutic.
Read MoreInflammation Identified As New Post-Stroke Therapeutic Target
The study found success in utilizing a new method of delivery of a potent biotechnology anti-inflammatory therapeutic. Pictured is a patient dialing a phone an hour after treatment, something he’d previously been unable to do after his stroke.
Read More